IL6 and breast cancer: investigated the simultaneous expression of IL-6 and IDO1 in patients with BC before neoadjuvant chemotherapy; they identified an association between IL-6 and IDO1 expression in advanced BC and an inferior response to neoadjuvant therapy.67